drugset / Trial / NCT02805504

Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

NCT02805504 ↗

Phase 4 Completed 136 enrolled Loma Linda University
RandomizedParallel-groupSingle-blindTreatment

Summary

A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.

Timeline

Start
2016-07-11
Primary completion
2022-05-09
Completion
2022-05-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — Other